TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer
NCT00828529
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Tuberculosis
HIV
Interventions
DRUG:
TMC207
Sponsor
Tibotec BVBA